Investors’ belief in a 2H EPS recovery is growing amid a stronger than expected reporting season. Meanwhile, the recent leading macro data have slowed further. We recommend owning high operational efficiency and earnings stability stories and offer related screens in today’s note. Investors’ belief in a 2H EPS recovery grows…The driving force behind the resiliency in earnings revisions breadth is…
Morgan Stanley: Weekly Warm-up: Earnings Revisions Stabilize As Macro Data Disappoints
A financial market resource for the every-day investor and trader.
-
Fitbit Q3 2016 Earnings Preview
Seth Golden, , Research Reports, 0
Fitbit (FIT) will report its Q3 2016 results after the closing bell on November 2nd and too much anticipation as both...
-
Morgan Stanley: Challenged Recovery, Fed Disappoints:
Seth Golden, , Research Reports, 0
Fed minutes disappoint with lack of inflation-targeting details or willingness to employ yield curve control. Meanwhile, the recovery is...
-
Marko Kolanovic/J.P. Morgan 2020 Outlook
Seth Golden, , Research Reports, 0
MACROECONOMIC OUTLOOK: Our view is that the market turmoil and economic slowdown over the past 18 months is not...
-
-
Lead Biotech Analysts Updates Vaccine Forecast
Seth Golden, , Research Reports, 0
Pfizer has not yet accrued the32 COVID infections for its 1st interim analysis: The fact that Pfizer’s first interim...
-
Weekly State of the Market: Key Investor Concerns
Seth Golden, , Research Reports, 0
Question: “How do you perform well over time and never let the volatility deter you?” Answer: “Position long, hope...
-
The S&P 500 Plotted Course Has Been Prepared
Seth Golden, , Research Reports, 0
The S&P 500 (SPX) came within 9 points of reaching it’s all-time record high earlier in the trading week...
-
Pivotal Point For Market Trend Lay Ahead: Review Your Process
Seth Golden, , Research Reports, 0
Everyday I read The Chart Report. It’s a mixture of charts and thoughtful quotes for what I find to...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00